Cook Medical Makes Its Case For Medicare New-Tech Add-On Payments
This article was originally published in The Gray Sheet
Executive Summary
Cook is seeking add-on payments for its Zilver PTX drug-eluting peripheral stent and Zenith AAA endovascular graft in 2013, addressing related CMS questions at a Feb. 14 new-technology “town hall” meeting.
You may also be interested in...
CMS Announces FY 2015 New-Tech Add-On Payment Applicants
Among the latest round of applicants announced Dec. 26 for the hospital inpatient, new-technology add-on payments are five device makers: Boston Scientific (Watchman), CardioMEMS (Champion HF), Abbott Vascular (MitraClip), NeuroPace (RNS), and Aptus Endosystems (Heli-FX EndoAnchor).
Four Firms Vie For Medicare 2014 New-Tech Add-On Payments
CMS held its annual new-technology Town Hall February 5, hearing from applicants for a drug-eluting peripheral artery stent, a neurostimulator system for epilepsy seizures, a transcatheter mitral valve repair system and a retinal prosthesis system.
Four Firms Vie For Medicare 2014 New-Tech Add-On Payments
CMS held its annual new-technology Town Hall Feb. 5, hearing from applicants for a drug-eluting peripheral artery stent, a neurostimulator system for epilepsy seizures, a transcatheter mitral valve repair system and a retinal prosthesis system.